Article Text

Download PDFPDF
Images in thorax
E-pipe use leading to lipoid pneumonia in Europe
  1. Anne-Catherine Kessler1,
  2. Corina Dommann2,
  3. Yvonne Nussbaumer-Ochsner1,3
  1. 1 Department of Internal Medicine, Spitäler Schaffhausen, Schaffhausen, Switzerland
  2. 2 Department of Pathology, Cantonal Hospital Winterthur, Winterthur, Switzerland
  3. 3 Department of Pneumology, Spitäler Schaffhausen, Schaffhausen, Switzerland
  1. Correspondence to Dr Yvonne Nussbaumer-Ochsner, Internal Medicine / Pneumology, Spitäler Schaffhausen, Schaffhausen 8208, Switzerland; yvonne.nussbaumer{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


A 53-year-old, so far healthy woman was admitted to the emergency department due to increasing cough and dyspnoea. Four days before presentation, the general practitioner initiated an outpatient treatment with amoxicilin/clavulanic acid due to the clinical and radiological suspicion of a bilateral, community-acquired pneumonia. Apart from escitalopram and oestrogen containing hormone replacement therapy, she did not use any medication. She had no pets or humidifier and worked as a saleswoman in a gift shop.

Three weeks before admission, she switched from conventional cigarettes to commercial available electronic pipe (nicotine content 4 mg/mL, taste of pipe tobacco and refillable tank). She performed inhalations approximately 4–5 times per day. She denied using cannabinoid-containing liquids and was no dual user. Ten days after starting consuming the electronic pipe, the patient suffered from dry cough and dyspnoea when hurrying upstairs.

On admission, the …

View Full Text


  • Contributors A-CK collected the data; A-CK and YN-O wrote the article; CD made the Analysis of the lung biopsies.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article.